Tag Archives: ricin
Dear Research Advocate:
On Wednesday, the House Appropriations agriculture subcommittee approved the funding bill that includes the Food and Drug Administration. The bill allocates nearly $100 million above the post-sequester levels. Unfortunately, the baseline budgets in the House are so low that this increase is still lower than FY12 FDA funding. We must not fall into the trap of lowering our expectations and applauding an artificial victory. The true mark of success is funding that keeps up with need. We must keep working.
As demonstrated particularly by the 18.6% cut targeted for the House LHHS appropriations FY14 budget, the pressure to shrink government by slashing discretionary spending shows no sign of abating. This pressure continues despite the damage nationwide in furloughs, layoffs, shuttered labs, patients turned away from clinical trials, and uncertainty around the ability of federal agencies to accomplish the basic government functions that help sustain an advanced society.
Speaking of mounting evidence against consequence-blind budget cuts, the lab that quickly identified the ricin toxin in letters sent recently to elected officials is CDC-funded. The Spokane (WA) Regional Health District Bioterrorism Lab is threatened with closure due to budget cuts (read more in the Homeland Security News Wire report). Of course it’s not only ricin-laced letters that must be stopped in their tracks. For example: The president has declared an emerging respiratory infection from the Middle East (known as MERS-CoV) a “potential public health emergency.” How can we expect the CDC to be effective in identifying, preventing and combating this or other global threats without the resources needed to do its job? Continue reading →